Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Dal Poggetto John

2. Date of Event Requiring Statement (MM/DD/YYYY) 9/27/2019

3. Issuer Name and Ticker or Trading Symbol

Sonoma Pharmaceuticals, Inc. [SNOA]

(Last) (First) (Middle)

1129 N. MCDOWELL BLVD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Financial Officer /

(Street)

PETALUMA, CA 94954

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.0001 par value per share	115	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	2/25/2010	2/25/2020	Common Stock	223	$576.45	D
Stock Option (right to buy)	5/17/2011	5/17/2021	Common Stock	286	$595.35	D
Stock Option (right to buy)	8/24/2015	8/24/2022	Common Stock	96	$292.95	D
Stock Option (right to buy)	9/19/2016	9/19/2023	Common Stock	238	$133.65	D
Stock Option (right to buy)	3/4/2017	3/4/2024	Common Stock	1648	$175.50	D
Stock Option (right to buy)	8/21/2015	8/21/2025	Common Stock	1251	$52.20	D
Stock Option (right to buy)	⁽¹⁾	8/21/2025	Common Stock	420	$52.20	D
Stock Option (right to buy)	⁽²⁾	4/11/2027	Common Stock	1334	$61.92	D

Explanation of Responses:
(1)	Options vest upon the achievement of certain goals.
(2)	Options vest in three equal tranches annually on the grant date anniversary, beginning on April 11, 2018 and becoming fully vested on April 11, 2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Dal Poggetto John 1129 N. MCDOWELL BLVD PETALUMA, CA 94954			Chief Financial Officer